Latest News for: Tanabe
Edit
Mineralys Therapeutics Announces Repurchase of Royalty Obligations in Tanabe License Agreement and Concurrent Financing
Nasdaq Globe Newswire 03 Jun 2026
– Repurchase of lorundrostat royalty obligation in Tanabe license agreement for $200 million upfront and up to $100 million once certain commercial milestones are met – ... .
Edit
Total Investment of Approx. USD 8.5 Million in Malaria and NTD R&D Projects With Partners Including MMV, GSK, Tanabe Pharma, Eisai and DNDi
PR Newswire 22 Apr 2026
Investment of approx ... This project is being led by Medicines for Malaria Venture (MMV), Tanabe Pharma Corporation in Japan, and the University of Georgia in the United States ... Investment of approx ... and MMV ... Appendix 1 ... 1 ... Tanabe Pharma Corporation (Japan).
Edit
The Ridgway Record
02 Apr 2026
Tanabe Pharma America Announces Finalization of RADICAVA (edaravone) Transfer to Shionogi
Tanabe Pharma America Remains Focused on Rare Disease Innovation and Addressing Unmet Patient Needs ....
Edit
Finding Strength in Shared Stories: Tanabe Pharma Canada Introduces New Book for the Canadian ALS ...
Canada Newswire 26 Mar 2026
TORONTO, March 26, 2026 /CNW/ -Tanabe Pharma Canada, Inc ... About Tanabe Pharma Corporation, Inc.Tanabe Pharma Corporation (TP) is one of the oldest pharmaceutical companies in the world, founded in 1678 ... SOURCE Tanabe Pharma Canada, Inc.
- 1